According to a new report by Polaris Market Research, the global mucormycosis market was valued at USD 422.7 million in 2020 and is projected to reach USD 616.1 million by 2028, expanding at a CAGR of 3.4% over the forecast period. Growth is underpinned by the rising prevalence of fungal infections among immunocompromised patients, an expanding pipeline of antifungal drugs, and growing public...
English
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)